DOI QR코드

DOI QR Code

Experimental Strategies for Induction of Gastric Adenocarcinomas under Long-Term Proton Pump Inhibitor Administration and Helicobacter Pylori Infection

  • Hagiwara, Tadashi (Department of Pathology, Shiga University of Medical Science) ;
  • Mukaisho, Ken-Ichi (Department of Pathology, Shiga University of Medical Science) ;
  • Nakayama, Takahisa (Department of Pathology, Shiga University of Medical Science) ;
  • Sugihara, Hiroyuki (Department of Pathology, Shiga University of Medical Science) ;
  • Hattori, Takanori (Department of Pathology, Shiga University of Medical Science)
  • Published : 2012.06.30

Abstract

Keywords

References

  1. Alarcon T, Domingi D, Sanchez I, et al (1998). In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori. Eur J Clin Microbiol & Infectious Dis, 17, 275-7.
  2. Hagiwara, T, Mukaisho, K, Ling, Z.-Q, et al (2007). Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats. Dig Dis Sci, 52, 1219-24. https://doi.org/10.1007/s10620-006-9253-7
  3. Hagiwara T, Mukaisho K, Nakayama T, et al (2011). Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori. Gut, 60, 624-30 https://doi.org/10.1136/gut.2010.207662
  4. Larsson H, Carlsson E, Hakanson R, et al (1988). Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology, 95, 1477-86.
  5. Midolo PD, Turnidge JD, Lambert JR, et al (1996). Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro. Antimicrob Agents Chemother, 40, 1531-3.
  6. Tatematsu M, Tsukamoto T, Mizoshita T (2005). Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils. Helicobacter, 10, 97-106. https://doi.org/10.1111/j.1523-5378.2005.00305.x
  7. Tsukamoto H, Mizoshita T, Sasaki M, et al (2012). Longterm High-dose Proton Pump Inhibitor Administration to Helicobacter pylori-infected Mongolian gerbils Enhances Neuroendocrine tumor Development in the Glandular Stomach. Asian Pacific J Cancer Prev, 12, 1049-54.

Cited by

  1. Proton Pump Inhibitors and Helicobacter Pylori-Associated Pathogenesis vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1315